Eric Crombez
Direttore Tecnico/Scientifico/R&S presso ULTRAGENYX PHARMACEUTICAL INC.
Patrimonio netto: 2 M $ in data 30/06/2024
Provenienza dei contatti di primo grado di Eric Crombez
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 43 | |
| Subsidiary | Biotechnology | 15 | |
Automobiles Vienne Sud
 Automobiles Vienne Sud Specialty StoresRetail Trade Part of ECL SAS, Automobiles Vienne Sud is a company that provides automobile dealership services. The company is based in Vienne, France. Automobiles Vienne Sud was acquired by ECL SAS on November 24, 2021.
1
| Subsidiary | Specialty Stores | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Eric Crombez tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| INTERMUNE INC | Biotechnology | Chief Operating Officer Chief Executive Officer Director/Board Member Sales & Marketing Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Compliance Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer | |
| 89BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Director/Board Member | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member General Counsel | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Chairman Investor Relations Contact | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| University of the Witwatersrand | College/University | Graduate Degree Doctorate Degree | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member Chairman | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chairman Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Doctorate Degree | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Irlanda | 4 |
| Svizzera | 2 |
| Sud Africa | 2 |
| Belgio | 2 |
Settori
| Health Technology | 37 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 267 |
| Corporate Officer/Principal | 128 |
| Independent Dir/Board Member | 127 |
| Chairman | 62 |
| Undergraduate Degree | 42 |
Contatti più connessi
| Insiders | |
|---|---|
| Georges Gemayel | 33 |
| Alan Colowick | 30 |
| Rishi Gupta | 29 |
| Arlene Morris | 28 |
| Daniel Welch | 24 |
| Donald Hayden | 23 |
| Lars Ekman | 21 |
| Deborah Dunsire | 20 |
| John Hohneker | 19 |
| George Migausky | 18 |
| Camille Bedrosian | 18 |
| Mardi Dier | 18 |
| Clay Siegall | 18 |
| Shalini Sharp | 17 |
| Michael Dybbs | 17 |
- Borsa valori
- Insiders
- Eric Crombez
- Connessioni Società
